<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE335nnn/GSE335480/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE335480</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Single-cell tracking reveals tumor-reactive T cell plasticity during melanoma TIL therapy</name><description>Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TILs) can induce durable responses in metastatic melanoma, yet the clonal and transcriptional dynamics that govern tumor-reactive T cell fate during ex vivo expansion and after transfer remain poorly understood. Here, we performed longitudinal single-cell RNA and T cell receptor (TCR) sequencing across five timepoints, from baseline tumors through a two-phase ex vivo expansion to post-infusion peripheral blood and tumor biopsies, in seven melanoma patients, generating a high-resolution map of both CD8+ and CD4+ tumor-reactive T cell plasticity. During early expansion (preREP), tumor-reactive CD8+ T cells were reinvigorated from an exhausted state and acquired distinct HLA-II-high or KLF2-high transcriptional profiles. In-depth characterization of the CD4+ compartment revealed lineage-dependent reinvigoration. After transfer, both CD8+ and CD4+ tumor-reactive clones acquired stem-like profiles and tissue-homing markers before re-infiltrating tumor lesions. Mechanistically, we identify two processes linked to treatment failure in non-responders: de novo expansion of immunosuppressive regulatory T cells, and co-transfer of Type 17 T cells. These data provide a comprehensive longitudinal framework of T cell plasticity during TIL-ACT.</description><dates><publication>2026/07/10</publication></dates><accession>GSE335480</accession><cross_references><GSM>GSM9814386</GSM><GSM>GSM9814387</GSM><GSM>GSM9814384</GSM><GSM>GSM9814385</GSM><GSM>GSM9814382</GSM><GSM>GSM9814383</GSM><GSM>GSM9814380</GSM><GSM>GSM9814381</GSM><GSM>GSM9814405</GSM><GSM>GSM9814406</GSM><GSM>GSM9814403</GSM><GSM>GSM9814404</GSM><GSM>GSM9814401</GSM><GSM>GSM9814402</GSM><GSM>GSM9814388</GSM><GSM>GSM9814389</GSM><GSM>GSM9814400</GSM><GSM>GSM9814409</GSM><GSM>GSM9814407</GSM><GSM>GSM9814408</GSM><GSM>GSM9814390</GSM><GSM>GSM9814397</GSM><GSM>GSM9814398</GSM><GSM>GSM9814395</GSM><GSM>GSM9814396</GSM><GSM>GSM9814393</GSM><GSM>GSM9814394</GSM><GSM>GSM9814391</GSM><GSM>GSM9814392</GSM><GSM>GSM9814416</GSM><GSM>GSM9814414</GSM><GSM>GSM9814415</GSM><GSM>GSM9814379</GSM><GSM>GSM9814412</GSM><GSM>GSM9814413</GSM><GSM>GSM9814399</GSM><GSM>GSM9814410</GSM><GSM>GSM9814411</GSM><GPL>24676</GPL><GSE>335480</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>